95 related articles for article (PubMed ID: 30902662)
41. [Human papillomavirus 16E6 gene mutation in cervical carcinoma tissues].
Sun F; Ha XQ; Lv TD; Xing CP; Liu B; Cao XZ
Ai Zheng; 2009 May; 28(5):478-82. PubMed ID: 19624874
[TBL] [Abstract][Full Text] [Related]
42. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
[TBL] [Abstract][Full Text] [Related]
43. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
44. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection.
Vince A; Lepej SZ
Med Glas (Zenica); 2010 Feb; 7(1):18-25. PubMed ID: 20387720
[TBL] [Abstract][Full Text] [Related]
46. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.
Bonetta AC; Mailly L; Robinet E; Travé G; Masson M; Deryckere F
Biochem Biophys Res Commun; 2015 Oct; 465(4):658-64. PubMed ID: 26241675
[TBL] [Abstract][Full Text] [Related]
47. Genomagnetic LAMP-based electrochemical test for determination of high-risk HPV16 and HPV18 in clinical samples.
Bartosik M; Jirakova L; Anton M; Vojtesek B; Hrstka R
Anal Chim Acta; 2018 Dec; 1042():37-43. PubMed ID: 30428986
[TBL] [Abstract][Full Text] [Related]
48. [Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction].
Ma CL; Li YJ; Zhang FC; Wang GQ; Zheng YJ; Kai LM; Re XD; Han Y; Patiguli
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):469-73. PubMed ID: 15061964
[TBL] [Abstract][Full Text] [Related]
49. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
50. Facile and direct detection of human papillomavirus (HPV) DNA in cells using loop-mediated isothermal amplification (LAMP).
Vo DT; Story MD
Mol Cell Probes; 2021 Oct; 59():101760. PubMed ID: 34364994
[TBL] [Abstract][Full Text] [Related]
51. Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA.
Ying J; Mao L; Tang Y; Fassatoui M; Song W; Xu X; Tang X; Li J; Liu H; Jian F; Du Q; Wong G; Feng W; Berthet N
Microbiol Spectr; 2023 Dec; 11(6):e0120723. PubMed ID: 37787547
[TBL] [Abstract][Full Text] [Related]
52. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
53. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
[TBL] [Abstract][Full Text] [Related]
54. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.
Hovland S; Muller S; Skomedal H; Mints M; Bergström J; Wallin KL; Karlsen F; Johansson B; Andersson S
Int J Oncol; 2010 Jun; 36(6):1533-9. PubMed ID: 20428778
[TBL] [Abstract][Full Text] [Related]
55. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study.
Collins SI; Constandinou-Williams C; Wen K; Young LS; Roberts S; Murray PG; Woodman CB
Cancer Res; 2009 May; 69(9):3828-32. PubMed ID: 19401452
[TBL] [Abstract][Full Text] [Related]
56. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
57. Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
Xiao H; Chen W; Lin M; Jiang S; Cui X; Zhao S
Anal Methods; 2024 Mar; 16(13):1862-1869. PubMed ID: 38463013
[TBL] [Abstract][Full Text] [Related]
58. Synergistically enhanced colorimetric molecular detection using smart cup: a case for instrument-free HPV-associated cancer screening.
Yin K; Pandian V; Kadimisetty K; Ruiz C; Cooper K; You J; Liu C
Theranostics; 2019; 9(9):2637-2645. PubMed ID: 31131058
[No Abstract] [Full Text] [Related]
59. Development of Enzymatic Recombinase Amplification Assays for the Rapid Visual Detection of HPV16/18.
Ding N; Qi W; Wu Z; Zhang Y; Xu R; Lin Q; Zhu J; Zhang H
J Microbiol Biotechnol; 2023 Aug; 33(8):1091-1100. PubMed ID: 37635316
[TBL] [Abstract][Full Text] [Related]
60. Rapid diagnosis of seven high-risk human papillomavirus subtypes by a novel loop-mediated isothermal amplification method.
Xi X; Cao WL; Yao X; Chen J; Huang D; Yang T; Liu Z; Xie W; Xia Y; Zhong T
Mol Cell Probes; 2022 Feb; 61():101787. PubMed ID: 34875349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
